Agilent Technologies Inc (A)

A (NYSE:Health Services)
neg -0.24
Today's Range: 55.89 - 56.53 | A Avg Daily Volume: 1,844,900
Last Update: 07/28/14 - 4:02 PM EDT
Volume: 1,506,425
YTD Performance: -1.15%
Open: $56.49
Previous Close: $56.53
52 Week Range: $44.66 - $61.22
Oustanding Shares: 333,260,908
Market Cap: 18,942,550,011
6-Month Chart
TheStreet Ratings Grade for A
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 9 9 9
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.22 1.20 1.20 1.20
Latest Dividend: 0.13
Latest Dividend Yield: 0.93%
Dividend Ex-Date: 06/27/14
Price Earnings Ratio: 26.94
Price Earnings Comparisons:
A Sector Avg. S&P 500
26.94 27.20 28.93
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
3.93% 21.15% 21.83%
Revenue -1.10 0.25 0.08
Net Income -37.20 0.06 0.02
EPS -35.80 0.08 0.02
Earnings for A:
Revenue 6.78B
Average Earnings Estimates
Qtr (07/14) Qtr (10/14) FY (10/14) FY (10/15)
Average Estimate $0.74 $0.95 $3.08 $3.40
Number of Analysts 9 8 9 9
High Estimate $0.78 $0.99 $3.12 $3.57
Low Estimate $0.73 $0.91 $3.05 $3.22
Prior Year $0.68 $0.81 $2.88 $3.08
Growth Rate (Year over Year) 8.99% 17.13% 6.87% 10.36%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Feb 14, 2014 | 8:04 AM EST
A lowered its numbers, Jefferies said. Moderated EMG core revenue growth outlook drives lower cash flow forecasts. $66 price target and...
Feb 14, 2014 | 7:48 AM EST
Shares of A now seen reaching $67, according to Leerink Swann. Estimates also reduced, given the company's new guidance. Outperform rat...

Agilent Tops the S&P 500 Real Money Pro($)

After today's big burst of momentum, it's set up well for more upside.

Not Buying This Rally Real Money Pro($)

Complacency is high, and we could soon be overbought again.
Oct 01, 2013 | 8:31 AM EDT
A was downgraded from Buy to Hold, Stifel Nicolaus said. Valuation call.  
Sep 20, 2013 | 8:37 AM EDT
A price target goes to $60 on EMG spin-off, said Jefferies.

Weaving Another Basket Real Money Pro($)

Building a new group of 15 names.
Aug 15, 2013 | 7:42 AM EDT
A earnings estimates were raised given strong cost controls, said Citigroup.  Price target is boosted to $53.
Jun 25, 2013 | 8:06 AM EDT
Rating on A was cut to Neutral, Goldman Sachs said. $47 price target. Company lacks near-term catalysts. 
May 15, 2013 | 7:30 AM EDT
A earnings estimates were reduced given FX headwinds and deterioration in EMG with the loss of a large wireless manufacturing customer,...

Columnist Conversations

I am still watching MON for a possible reversal against the time/price parameters. So far we are not seeing a...
Market stages nice comeback from early losses to end basically flat. Gilead Sciences (GILD)has a nice day post...
Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Before: Transparency is...
Going to $47 without Otis...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.